Modern kinetic spectrophotometric procedure for estimation of furosemide drug as bulk form and in pharmaceuticals preparations
PDF

Keywords

kinetic
spectrophotometric method
determination
furosemide drug
pharmaceuticals preparations

Abstract

A simple, rapid, sensitive, inexpensive and easy to perform kinetic spectrophotometric procedure for the investigation of trace quantities of the drug, furosemide (FRO), as bulk and in the pharmaceutical preparations, has been improved upon. The enhanced method was depended on the fashioning of the Schiff ‘s base by the reaction of the aldehyde group present in the 5-sulfo salicylaldehyde reagent, and the primary amino group present in furosemide. The latter acts as a ligand for the formation of an intense colored complex with Co(II) in an acidic medium, with maximum absorption at 608 nm. In the work, kinetic spectrophotometrics were established through the fixed time method. Moreover, Beer’s law was applied on the range of concentration between 5-100 ppm, while the molar absorptivity and the Sandell sensitivity were 3.9295×104 l.mol−1cm−1, 0.008 μg.cm−2, respectively. The detection limit (LOD) was 2.133 µg/ml−1, and LOQ was 1.105 µg/ml−1. Ideal circumstances for all colour improvement were seen, and the suggested procedure has been effectively employed in investigating amounts of furosemide (FRO) in bulk forms and in pharmaceutical preparations (tablets, injection sample). Additives and general excipient materials did not affect the studied method. A statistical comparison between the results that were obtained from the reference method gave good agreement.

PDF

References

1. Abdel-Hamid M.E.: High-performance liquid chromatograghy – mass spectrometric analysis of furosemide in plasma and its use in pharmacokinetic studies. Farmaco, 55, 448, 2000.

2. Abdul Satar R.S. (2006). Development of new spectrophotometric methods for determination of some organic drug compounds in pharmaceutical preparations. “Ph. D. Thesis”, Baghdad University”.

3. Al-Enizzi M.S.: Spectrophotometric method for Assay of Salbutamol in Pharmaceutical Formulations. Tikrit J. of Pure Science, 13(2), 90, 2008.

4. Al-Rufaie M.M., Al-Sharefy A.N., Kathem K.H.: Spectrophotometric Determination of Doxycycline Hyclate in Pharmaceutical Preparations Using Oxidative coupling reaction. J. of Applicable Chemistry, 2(4), 931, 2013.

5. Al-Rufaie M.M.: New spectrophotometric method for the determination of Sulfamethoxazole drug. W. J. of pharmacy and pharmaceutical sciences. 5(3), 172, 2016.

6. Al-Rufaie M.M., Al-Sharefy A.N., Kathem K.H.: New spectrophotometric method for the determination chlorpromazine hydrochloride in pharmaceutical preparations by using oxidative coupling reaction. Inter. J. of Uni. Pharmacy and Bio Sciences, 2(4), 19, 2013.

7. Andres, G. (1986). Medical Pharmacology. 8 ed., The C. V. Mosby Company, Japan, p 435.

8. Bahattacharya M., Iqbal S.A., Malik S.: Studies on Furosemide salicyladehyde Schiff base complex with copper (II) and zinc(II). Asian J. of Chemistry, 18(1), 715, 2006.

9. Bertran G.K.(1992). Basic and Clinical Pharmacology. 5 ed., Appleton and Lange: U.S.A., p 217.

10. British Pharmacopoeia, Her Majesty’s Stationary Office. (2009). London, p.5729, 8497, 8499.

11. Carda-Broch S. et al.: Determination of furosemide in urine samples by direct injection in micellar liquid chromatograghy system. Analyst., 127, 29, 2002.

12. Ferrero M.C., Castellano P.M., Kaupman, T. S.: A spectrophotometric partial least squares (PLS-1) simultaneous determination of furosemide and amiloride hydrochloride in pharmaceutical formulations. J. Pharm.Biomed. Analysis, 26, 443, 2001.

13. Garcia M.S. et al.: Flow-injection spectrophotometric determination of furosemide or sulphathiazole in pharmaceuticals. J. Pharm. Biomed. Analysis, 15, 453, 1997.

14. Goto T. et al: Colometric determination of furosemide in drug dosage forms. Eiseigaku Zassi, 43, 95, 2002.

15. Hassouna M.EA., Issa Y.M., Sayed. A.G.: Spectrophotometric Determination of Furosemide Drug in Different Formulations using Schiff’s Bases. Forensic Res. Criminol Int. J., (1)6, 36, 2015.

16. Ines-Toral M. et al.: Simultaneous determination of amiloride and furosemide in pharmaceutical formulations by first digital derivative spectrophotometry. P. Int. J. Pharm. 2002, 249, 117.

17. Jankowski A., Skorek-Jankowska A., Lamparczyk H.: Determination and pharmacokinetics of a furosemide-amiloride drug combination. J. Chromatogr B Biomal Sci Appl., 693, 383, 1997.

18. Merck index (13th ed). (2006). Merck and Co, USA, p.764.

19. Nagaraja P., Shrestha A.K.: Simultaneous determination of aceclofenac, paracetamol and chlorzoxazone by HPLC in tablet dose form. E-J. Chemistry, 7(2), 395, 2010.

20. Negoui M. Synthesis and Characterisation of Complex Cu(II) Combinations with Schiff base Ligands derived from 4-amino-1-phenyl-2, 3-dimethyl-3-pyrazole-5-one (4-aminoantipyrine) and Pentatonic Heterocyclic Aldehydes. Rev. Chim. (Bucharest), 61(8), 762, 2010.

21. Nema R.K., Meyyanathan S.N., Sharma C.S., Verma M., Bhan C.S. (2008). Practical Approach to Pharmacetical analysis. CBS Publishers & New Delhi, India, p.51.

22. Nour El-Dien F.A. et al.: Two Spectrophotometric Assays for Dopamine Derivatives in Pharmaceutical Products and in Biological Samples of Schizophrenic Patients Using Copper Tetramine Complex and Triiodide Reagent. J. Biomed. & Biotech, 1, 2005.

23. Raja G.V. et al.: Simple spectrophotometric methods for the determination of sulfamethaxazole in pharmaceuticals using folinciocalteau and orcinol as reagents. E-J. Chemistry, 6(2), 357, 2009.

24. Ribeiro P.R.S. et al.: Flow-injection spectrophotometric determination of methyldopa in pharmaceutical formulations. Talanta, 67, 240, 2005.

25. Rosu T. et al.: Copper(II) Complexes with Ligands Derived from 4-Amino-2, 3-dimethyl-1-phenyl-3-pyrazolin-5-one. Synthesis and Biological Activity, Molecules, 11, 904, 2006.

26. Sevillano-Labeza A., Campins-Falco P., Serradov-Garcia M.C.: Extractive spectrophotometric determination of furosemide with sudium 1,2-naphthoquinone-4-sulphonate in pharmaceutical formulations. Anal. Letters, 30, 91, 1997. [Crossref]

27. Sheikhshoaie I.: Synthesis and charactrazation of schiff base complexes of cobalt(II). Asian J. of Chemistry, 18(2), 942, 2006.

28. Shirke P.P.et al.: Novel procedure for the quantitive assay of furosemide in pure form. J. Indian Chem. Soc., 73, 445, 1996.

29. Shukrallah I.Z., Sakla A.B.: Comparative study of some methods for the determination of the analgesic anti-inflammatory compound IS4(anisyldeneamino antipyrine. J. Chin. Chem. Soc., 33, 221, 1986.

30. The United States Pharmacopoeia. (1995). 23 ed., p 697.

31. US Pharmacopoeia XXIIth Rev. (2007). US Pharmacopoeia Convention, p. 294.

32. Walash M.I., Sharaf-El-Din M.K., Metwally M.E.: Kinetic spectrophotometric determination of ranitidine. J. Chin. Chem. Soc., 51, 523, 2004.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 Unported License.

Copyright (c) 2017 Authors

Downloads

Download data is not yet available.